1.
Hussein M, Berenson JR, Niesvizky R, Munshi N, Matous J, Sobecks R, Harrop K, Drachman JG, Whiting N. A phase I multidose study of dacetuzumab (SGN-40; humanized anti-CD40 monoclonal antibody) in patients with multiple myeloma. Haematologica [Internet]. 2010May4 [cited 2026Nov.17];95(5):845-8. Available from: https://haematologica.org/article/view/5600